Literature DB >> 33112638

Literature review on virus and host response proteins in COVID-19: pathobiology, management, diagnosis and treatment.

Ragheswari Rajaraman, Dhanina Yedida, SunilGowda Sunnaghatta Nagaraja, Ilakya Selvakumar, Pooja Ramakrishnan, Prakash Shankaran, Natesan Vasanthakumar, S Suma Mohan, Devipriya Nagarajan.   

Abstract

Coronavirus disease 2019 (COVID-19) is a severe acute respiratory syndrome caused by a novel strain of coronavirus (SARS-CoV-2) which was declared by WHO as a cause of global pandemic. By human-to-human transmission it caused severe damage to mankind with increased mortality rate worldwide. Coronavirus is a spherical enveloped virus with single stranded positive-sense RNA with a size of ~30 kilobases encoding various structural, non-structural and accessory proteins. The entry of coronavirus into the host cells is mediated by spike proteins. SARS-CoV-2 efficiently replicates in host cell and by evading immune surveillance, like innate and adaptive immune responses, in the host cells ultimately leads to increased virulence and disease outcome. In the current review, we highlighted the molecular insights of SARS-CoV-2 and its infection mechanism in the host cell via host-viral protein interactions based on currently available data up to 16thMay 2020 using various research literature databases. The diagnostics of SARS-CoV-2 is mainly done by RT-qPCR and serological tests. There is no effective treatment for COVID-19, however, few methods like plasma therapy and remdesivir treatment are reported to show promising results in improving patient's health and decreasing mortality rate. Keywords: SARS-CoV; spike protein; nucleocapsid; COVID-19; interferon.

Entities:  

Mesh:

Year:  2021        PMID: 33112638     DOI: 10.4149/av_2021_103

Source DB:  PubMed          Journal:  Acta Virol        ISSN: 0001-723X            Impact factor:   1.162


  2 in total

1.  Seroprevalence of SARS-CoV-2 Assessed by Four Chemiluminescence Immunoassays and One Immunocromatography Test for SARS-Cov-2.

Authors:  Pellegrino Cerino; Alfonso Gallo; Biancamaria Pierri; Carlo Buonerba; Denise Di Concilio; Maria Concetta Cuomo; Lucia Vassallo; Gabriella Lo Conte; Annachiara Coppola; Antonio Pizzolante; Giovanni Boccia; Veronica Ferrucci; Luigi Atripaldi; Maria Triassi; Daniela Pacella; Michele Cennamo; Paolo Romano; Teresa Maria Sorbo; Alessandro Furno; Oriana Catapano; Aldo Contina; Giuseppe Perruolo; Maurizio D'Amora; Daniela Terracciano; Giuseppe Portella
Journal:  Front Public Health       Date:  2021-04-29

2.  Monoclonal antibody pairs against SARS-CoV-2 for rapid antigen test development.

Authors:  Nol Salcedo; Ankita Reddy; Adam R Gomez; Irene Bosch; Bobby Brooke Herrera
Journal:  PLoS Negl Trop Dis       Date:  2022-03-31
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.